Skip to main content
. Author manuscript; available in PMC: 2014 Aug 8.
Published in final edited form as: Tohoku J Exp Med. 2012;227(4):253–262. doi: 10.1620/tjem.227.253

Table 6.

Demographic and biochemical features of subjects with and without rs10865710* variation

GG GC + CC P-value
n 107 761 NA
Gender(M/F) 27 / 80 194 / 567 0.954
Body height(cm) 158.14 ± 8.33 156.46 ± 8.03 0.033
Body weight(kg) 57.58 ± 11.73 55.84 ± 10. 52 0.134
BMI(kg/m2) 22.92 ± 3.54 22.73 ± 3.43 0.633
SBP(mmHg) 126.85 ± 21.05 127.60 ± 21.03 0.678
DBP(mmHg) 80.00(75.00 – 86.00) 80.00(70.00 – 88.00) 0.398
Waist(cm) 79.26 ± 11.34 77.57 ± 10.29 0.178
Hip(cm) 93.41 ± 7.64 92.05 ± 7.42 0.095
WHR 0.85 ± 0.09 0.84 ± 0.08 0.735
FPG(mmol/L) 5.57 ± 1.29 5.38 ± 1. 84 0.026
TG(mmol/L) 1.57 ± 1.56 1.49 ± 1. 27 0.643
HDLc(mmol/L) 1.54 ± 0.46 1.60 ± 0. 77 0.396
LDLc(mmol/L) 2.57 ± 0.91 2.67 ± 0.90 0.201
TC(mmol/L) 5.41 ± 1.09 5.50 ± 1.11 0.471
ALT(mmol/L) 24.16 ± 25.15 21.30 ± 16.97 0.388
AST(mmol/L) 29.00 ± 15.85 28.03 ± 10.91 0.751
GGT(U/L) 29.95 ± 22.16 26.14 ± 19.17 0.079
ALP(U/L) 76.17 ± 24.69 77.88 ± 26.05 0.602
FINS(mlU/L) 6.04(3.89 – 9.54) 5.68(3.71 – 8.79) 0.306
HOMA-IR 1.44(0.93 – 2.45) 1.42(0.86 – 2.28) 0.592
HSCRP(mg/L) 1.00(1.00 – 2.40) 1.00(1.00 – 2.30) 0.475
MS(+/−) 25 / 82 (23.4%) 130 / 631 (17.1%) 0.112

ALP, alkaline phosphatase ; ALT, alanine transaminase; AST, aspartate transaminase; BMI, body mass index; DBP, diastolic blood pressure; FPG, fasting plasma glucose; FINS, fasting insulin; GGT, gamma-glutamyl transpeptidase; HDLc, high-density lipoprotein cholesterol; HOMA-IR, homoeostatic metabolic assessment insulin resistance index; HSCRP, high sensitive C-reactive protein; LDLc, low-density lipoprotein cholesterol; MS, metabolic syndrome; NA, not analyzed; NAFLD, non-alcoholic fatty liver disease; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride; WHR, waist-to-hip ratio.

Continuous data with skewed distribution

*

rs10865710=C-681G